Your browser doesn't support javascript.
loading
A partner protection package for HIV cure-related trials involving analytical treatment interruptions.
Dubé, Karine; Morton, Tia; Fox, Lawrence; Dee, Lynda; Palm, David; Villa, Thomas J; Freshwater, William; Taylor, Jeff; Graham, Gail; Carter, William B; Sauceda, John A; Peluso, Michael J; Rid, Annette.
Affiliation
  • Dubé K; Division of Infectious Diseases and Global Public Health, University of California San Diego School of Medicine, La Jolla, CA, USA; University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC, USA. Electronic address: kdube@health.ucsd.edu.
  • Morton T; Division of AIDS, National Institute of Allergy and Infectious Diseases, Rockville, MD, USA.
  • Fox L; Division of AIDS, National Institute of Allergy and Infectious Diseases, Rockville, MD, USA.
  • Dee L; Delaney AIDS Research Enterprise Community Engagement and Community Advisory Board University of California San Francisco, Department of Medicine, HIV, ID and Global Medicine, San Francisco, CA, USA; AIDS Action Baltimore, Baltimore, MD, USA.
  • Palm D; AIDS Clinical Trials Group Global Community Advisory Board, Chapel Hill, NC, USA; Institute of Global Health and Infectious Diseases Clinical Trials Unit, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Villa TJ; HIV Obstruction by Programmed Epigenetics Delaney Collaboratory Community Advisory Board, Gladstone Institutes, San Francisco, CA, USA; National HIV & Aging Advocacy Network, National Minority AIDS Council, Washington, DC, USA; Reversing Immune Dysfunction HIV Delaney Collaboratory Community Adv
  • Freshwater W; Philadelphia, PA, USA.
  • Taylor J; Delaney AIDS Research Enterprise Community Engagement and Community Advisory Board University of California San Francisco, Department of Medicine, HIV, ID and Global Medicine, San Francisco, CA, USA; Reversing Immune Dysfunction HIV Delaney Collaboratory Community Advisory Board, Scripps Research, L
  • Graham G; Baltimore, MD, USA.
  • Carter WB; Baltimore, MD, USA; BEAT-HIV Collaboratory Delaney Community Advisory Board, Wistar Institute, Philadelphia, PA, USA.
  • Sauceda JA; Center for AIDS Prevention Studies, Division of Prevention Sciences, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA.
  • Peluso MJ; Department of Medicine, Division of HIV, Infectious Diseases, and Global Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA.
  • Rid A; Department of Bioethics, NIH Clinical Center, Bethesda, MD, USA.
Lancet Infect Dis ; 23(10): e418-e430, 2023 10.
Article in En | MEDLINE | ID: mdl-37295453
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections Type of study: Guideline Limits: Humans Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections Type of study: Guideline Limits: Humans Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2023 Type: Article